|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/553 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 31/706 | (2006.01) | ||
| A61K 31/706 | (2013.01) | ||
| A61K 31/5365 | (2006.01) | ||
| A61K 31/553 | (2013.01) | ||
| A61K 31/635 | (2006.01) | ||
| A61K 31/5365 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/635 | (2013.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Patento numeris | 4125915 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21718410.0 |
| Europos patento paraiškos padavimo data | 2021-03-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2021/023436 |
| Data | 2021-03-22 |
| (87) | Numeris | WO 2021/194946 |
| Data | 2021-09-30 |
| (30) | Numeris | Data | Šalis |
| 202062993254 P | 2020-03-23 | US | |
| 202063024713 P | 2020-05-14 | US | |
| 202063053875 P | 2020-07-20 | US |
| (72) |
BROOKS, Nathan Arthur , US
GILMOUR, Raymond , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR |
| COMBINATION THERAPY WITH A MUTANT IDH INHIBITOR |